润丰股份(301035):2024年第一季度经营概要（英文版）
|
时间：2024年05月10日 17:20:54 中财网 |
|
原标题: 润丰股份:2024年第一季度经营概要（英文版）
SHANDONG WEIFANG RAINBOW CHEMICAL CO., LTD
Operating Summary for the First Quarter of 2024
The Company and all members of the Board of Directors warrant that the contents of the Semi-annual Report are true,
accurate and complete, without false records, misleading statements or major omissions.
Important Notes:
1. The Board of Directors, Board of Supervisors, directors, supervisors and senior management warrant that the contents of the
Quarterly Report are true, accurate and complete, without false records, misleading statements or major omissions, and shall
bear individual and collective legal liabilities.
2. The legal representative of the Company, the chief accountant in charge, and the chief of the accounting institution
(accounting supervisor), stated that the financial report in the Quarterly Report is true, accurate and complete.
3. Whether the First Quarter Report is audited
□ Yes ?No
I. Key Financial Data
(I) Key Accounting Data and Financial Indicators
Whether the Company needs to retroactively adjust or restate the accounting data of previous years □ Yes ?No
| | Q1 2024 | Q1 2023 | Year-on-year increase or
decrease (%) | | Operating income (RMB) | 2,693,191,598.95 | 2,233,266,009.68 | 20.59% | | Net profit attributable to
shareholders of the Company
(RMB) | 152,843,351.25 | 182,814,094.72 | -16.39% | | Net profit attributable to
shareholders of the Company
excluding non-recurring gains
and losses (RMB) | 151,462,097.05 | 182,952,103.05 | -17.21% | | Net cash flow from operating
activities (RMB) | -297,983,503.10 | -438,843,869.41 | 32.10% | | Basic earnings per share
(RMB/Share) | 0.55 | 0.66 | -16.67% | | Diluted earnings per share
(RMB/Share) | 0.54 | 0.65 | -16.92% | | Weighted average return on
net assets | 2.29% | 2.91% | -0.62% | | | End of Q1 2024 | End of 2023 | Increase/Decrease at the
end of the current reporting
period compared with the
end of the previous year (%) | | Total assets (RMB) | 15,058,876,550.60 | 14,897,954,098.13 | 1.08% | | Equity attributable to
shareholders of the Company
(RMB) | 6,795,513,988.12 | 6,546,153,851.24 | 3.81% |
(II) Items and Amounts of Non-recurring Gains and Losses
? Applicable □ Not applicable
| Item | Amount of Q1 2024 | Notes | | Gains and losses on disposal of non-
current assets (including write-offs of
asset impairment provisions) | 116,607.39 | | | Government subsidies included in the
current gains and losses (excluding the
government subsidies closely related to
regular businesses of the Company, in
line with national policies, received by a
standard quota or quantity, and
consecutively affecting the Company's
gains and losses) | 1,834,359.29 | | | Gains and losses arising from changes in
the fair value of financial assets and | 31,929.16 | |
| liabilities held by non-financial
companies, and gains and losses from
the disposal of financial assets and
liabilities, other than the effective
hedging business related to the normal
operation of the Company | | | | Other non-operating revenue and
expenditure other than those
mentioned above | -325,600.88 | | | Less: affected amount of income tax | 248,594.24 | | | Affected amount of minority
shareholders' equity (after tax) | 27,446.52 | | | Total | 1,381,254.20 | -- |
Other gains and losses items that meet the definition of non-recurring gains and losses □ Applicable ? Not applicable
There are no other gains and losses items of the Company that meet the definition of non-recurring gains and loss.
Reasons for the non-recurring profit and loss items listed in Explanatory Announcement on Information Disclosure for Companies
Offering Their Securities to the Public No.1 - Non-recurring Gains and Losses recognized as recurring gains and losses items
□ Applicable ?Not applicable
There is no circumstance where the non-recurring profit and loss items listed in Explanatory Announcement on Information
Disclosure for Companies Offering Their Securities to the Public No.1 - Non-recurring Gains and Losses are recognized as recurring
gains and losses items.
(III) Changes to Key Accounting Data and Financial Indicators and Reasons ? Applicable □ Not applicable
1. Balance sheet items
| Item | March 31, 2024 | December 31, 2023 | Percentage of
change
(%) | Reason for change | | Notes receivable | 26,894,863.25 | 55,955,879.66 | -51.94% | Mainly due to the
decrease in endorsed
promissory notes
outstanding during the
reporting period | | Pre-payments | 247,513,918.87 | 129,020,462.65 | 91.84% | Mainly due to the
increase in pre-
payments for materials
during the reporting
period | | Development expenditure | 86,991,768.53 | 36,791,601.49 | 136.44% | Mainly due to the
increase in capitalized
expenditures such as
test fees related to
partial registration
during the reporting
period | | Short-term loan | 3,007,176,826.17 | 2,261,455,023.95 | 32.98% | Mainly due to the
increase in bank
borrowings during the
reporting period | | Derivative financial liabilities | 0.00 | 4,141,579.45 | -100.00% | Mainly due to the value
fluctuation of forward
exchange settlement |
business during the
reporting period
| Advance receipts | 490,412.00 | 232,358.87 | 111.06% | Mainly due to the
increase in rent of
Runke's building during
the reporting period | | Contract liability | 46,778,786.28 | 29,592,998.73 | 58.07% | Mainly caused by
increase in customer
payments accepted in
advance during the
reporting period | | Taxes payable | 125,548,394.22 | 77,730,510.55 | 61.52% | Mainly due to the
increase in tax payable
during the reporting
period | | Non-current liabilities due within one year | 4,560,445.18 | 9,623,075.76 | -52.61% | Mainly due to the
decrease in long-term
loans due within one
year during the
reporting period | | Other current liabilities | 23,007,785.61 | 57,442,707.33 | -59.95% | Mainly due to the
decrease in endorsed
promissory notes
outstanding during the
reporting period | | Long-term loan | 111,160,672.69 | 77,624,331.91 | 43.20% | Mainly due to the
increase in borrowings
of the subsidiary Ningxia
Gerui during the
reporting period |
2. Income statement items
| Item | January-March 2024 | January-March 2023 | Percentage of
change
(%) | Reason for change | | Sales expenses | 136,012,126.19 | 75,879,447.34 | 79.25% | Mainly due to the increase in
overseas market expansion
expenses, employee
remunerations and registration
expenses during the reporting
period | | R&D expenditures | 36,086,891.09 | 56,162,380.67 | -35.75% | Mainly due to the decrease in
R&D costs and expenses
caused by the decrease in R&D
material prices during the
reporting period | | Investment returns | 5,221,370.46 | -35,302,194.73 | 114.79% | Mainly due to investment
income from disposal of
derivative financial assets
during the reporting period | | Income from changes in fair value | 8,508,624.49 | 96,528,024.70 | -91.19% | Mainly due to the changes in
fair value of derivative financial
assets during the reporting
period | | Credit impairment losses | -15,533,971.25 | 27,806,314.28 | -155.86% | Mainly due to credit
impairment losses of accounts
receivable during the reporting
period |
Mainly due to reserve for
Asset impairment losses -534,514.34 -1,406,215.58 61.99% inventory depreciation during the reporting period
| Income tax expenses | 24,726,415.53 | 9,733,671.77 | 154.03% | Mainly due to the increase in
deferred income tax arising
from the offsetting of
unrealized internal trading
gains and losses during the
reporting period |
3. Cash flow statement items
| Item | January-March 2024 | January-March 2023 | Percentage of
change
(%) | Reason for change | | Net cash flow from operating activities | -297,983,503.10 | -438,843,869.41 | 32.10% | Mainly due to the year-on-
year decrease in collected
payments | | Net cash flow from financing activities | 283,264,392.84 | 649,322,860.48 | -56.38% | Mainly due to the increase
in cash paid for repayment
of bank borrowings |
II. Shareholder Information
(I) The number of common shareholders, the number of preferred shareholders whose voting rights have
been restored and the shareholdings of the top ten shareholders Unit: Share
| Number of common shareholders
as of the end of Q1 2024 | 6,225 | Number of preferred shareholders whose voting
rights have been restored as of the end of Q1 2024
(if any) | 0 | | | | | Shareholdings of the top 10 shareholders (excluding shares lent through stock pledge repos) | | | | | | | | Name of
shareholder | Shareholder
nature | Shareholding
ratio (%) | Shareholding
quantity | Quantity of
restricted
shares held | Pledge, mark or freeze | | | | | | | | Share status | Quantity | | Shandong
Rainbow
Investment Co.,
Ltd | Domestic non-
state-owned
legal person | 41.24% | 114,911,237.00 | 114,911,237.00 | Pledge | 22,880,000.00 | | KONKIA INC | Overseas legal
person | 21.96% | 61,191,800.00 | 61,191,800.00 | Not applicable | 0.00 | | Shandong
Rainbow
Agriculture
Investment Co.,
Ltd. | Domestic non-
state-owned
legal person | 4.70% | 13,105,690.00 | 13,105,690.00 | Not applicable | 0.00 | | Jinan Xinbo
Investment Co.,
Ltd. | Domestic non-
state-owned
legal person | 2.81% | 7,840,686.00 | 0.00 | Pledge | 6,827,700.00 | | Pei Xubo | Domestic
natural person | 2.80% | 7,799,613.00 | 0.00 | Not applicable | 0.00 | | Orient
Securities
Company | Other | 2.79% | 7,780,085.00 | 0.00 | Not applicable | 0.00 |
| Limited -
Zhonggeng
Value Pioneer
Equity
Securities
Investment
Fund | | | | | | | | Industrial and
Commercial
Bank of China
Co., Ltd. -
BOCOM
Schroder Trend
Priority Hybrid
Securities
Investment
Fund | Other | 2.67% | 7,428,254.00 | 0.00 | Not applicable | 0.00 | | China
Merchants
Bank Co., Ltd. -
BOCOM
Schroder
Qicheng Hybrid
Securities
Investment
Fund | Other | 1.08% | 3,004,957.00 | 0.00 | Not applicable | 0.00 | | Industrial and
Commercial
Bank of China
Co., Ltd. - E
Fund ChiNext
Trading Open-
End Index
Securities
Investment
Fund | Other | 0.66% | 1,832,083.00 | 0.00 | Not applicable | 0.00 | | Guotai Asset
Management
Co., Ltd. - Social
Security Fund
421 | Other | 0.54% | 1,500,241.00 | 0.00 | Not applicable | 0.00 | | Shareholding of top ten shareholders of unrestricted shares | | | | | | | | Name of shareholder | Quantity of unrestricted shares held | Type of shares | | | | | | | | Type of shares | Quantity | | | | | Jinan Xinbo Investment Co., Ltd. | 7,840,686.00 | RMB-
denominated
common
shares | 7,840,686.00 | | | | | Pei Xubo | 7,799,613.00 | RMB-
denominated
common
shares | 7,799,613.00 | | | | | Orient Securities Company Limited
- Zhonggeng Value Pioneer Equity
Securities Investment Fund | 7,780,085.00 | RMB-
denominated
common
shares | 7,780,085.00 | | | | | Industrial and Commercial Bank of | 7,428,254.00 | RMB- | 7,428,254.00 | | | |
| China Co., Ltd. - BOCOM Schroder
Trend Priority Hybrid Securities
Investment Fund | | denominated
common
shares | | | China Merchants Bank Co., Ltd. -
BOCOM Schroder Qicheng Hybrid
Securities Investment Fund | 3,004,957.00 | RMB-
denominated
common
shares | 3,004,957.00 | | Industrial and Commercial Bank of
China Co., Ltd. - E Fund ChiNext
Trading Open-End Index Securities
Investment Fund | 1,832,083.00 | RMB-
denominated
common
shares | 1,832,083.00 | | Guotai Asset Management Co.,
Ltd. - Social Security Fund 421 | 1,500,241.00 | RMB-
denominated
common
shares | 1,500,241.00 | | Hong Kong Securities Clearing
Company Ltd. (HKSCC) | 1,498,300.00 | RMB-
denominated
common
shares | 1,498,300.00 | | China Construction Bank
Corporation - Guotai Great Health
Equity Securities Investment Fund | 1,389,088.00 | RMB-
denominated
common
shares | 1,389,088.00 | | Yuanxin (Zhuhai) Private Equity
Fund Management Co., Ltd. -
Yuanxin China Value Growth No. 9
Private Securities Investment
Fund | 1,350,024.00 | RMB-
denominated
common
shares | 1,350,024.00 | | Explanation of the above-mentioned shareholder
relationship or concerted action | 1. Shandong Runyuan Investment Co., Ltd., KONKIA INC, Shandong
Rainbow Agrosciences Investment Co., Ltd. are enterprises controlled
by Wicky Wang, Sun Guoqing and Qiu Hongbing, the actual controllers
of the Company.
2. The Company is not aware whether the above-mentioned other
shareholders are associated or are persons acting in concert. | | | | Engagement of the top 10 shareholders in securities
margin trading business (if any) | 1. Pei Xubo holds 6,799,613 shares through the customer credit
transaction guarantee securities account of CITIC Securities (Shandong)
Co., Ltd., and 1,000,000 shares through common securities. A total of
7,799,613 shares are held by Pei Xubo.
2. Yuanxin (Zhuhai) Private Equity Fund Management Co., Ltd. - Yuanxin
China Value Growth No. 9 Private Securities Investment Fund holds
1,350,024 shares through the customer credit transaction guarantee
securities account of CITIC Securities Co., Ltd., and 0 shares through
common securities, totaling 1,350,024 shares. | | |
Participation of the shareholders holding more than 5% of shares, top 10 shareholders and top 10 shareholders with unlimited
shares outstanding in lending out shares under stock pledge repo transactions ? Applicable □ Not applicable
Unit: Share
| Participation of the shareholders holding more than 5% of shares, top 10 shareholders and top 10 shareholders with
unlimited shares outstanding in lending out shares under stock pledge repo transactions | | | | | | | | | | Name of
shareholde
r (in full) | Common account and
credit account holdings
at the beginning of the
period | | Shares lent through stock
pledge repo transactions
at the beginning of the
period and not yet
returned | | Common account and
credit account holdings
at the end of the period | | Shares lent through stock
pledge repo transactions
at the end of the period
and not yet returned | | | | Total | Proportion | Total | Proportion | Total | Proportion | Total | Proportion |
| | quantity | to total
shares | quantity | to total
shares | quantity | to total
shares | quantity | to total
shares | | Industrial
and
Commercia
l Bank of
China Co.,
Ltd. - E
Fund
ChiNext
Trading
Open-End
Index
Securities
Investment
Fund | 1,268,569 | 0.46% | 110,900 | 0.04% | 1,832,083 | 0.66% | 103,400 | 0.03% |
Changes from the previous period due to lending/returning via stock pledge repo transactions by top 10 shareholders and top 10
shareholders with unlimited shares outstanding
□ Applicable ? Not applicable
III. Quarterly Financial Statements
(I) Financial Statements
1. Consolidated balance sheet
Prepared by: Shandong Weifang Rainbow Chemical Co., Ltd.
March 31, 2024
| Item | Closing balance | Opening balance | | Current assets: | | | | Monetary funds | 2,610,782,485.67 | 3,271,577,916.51 | | Deposit reservation for balance | | | | Lending to banks and other financial
institutions | | | | Financial assets held for trading | 6,000,000.00 | 6,000,000.00 | | Derivative financial assets | 4,504,554.15 | | | Notes receivable | 26,894,863.25 | 55,955,879.66 | | Accounts receivable | 5,137,700,424.79 | 4,707,041,417.82 | | Receivables financing | | 500,000.00 | | Pre-payments | 247,513,918.87 | 129,020,462.65 | | Premium receivable | | | | Re-insurance accounts receivable | | | | Reserves for re-insurance contract
receivable | | | | Other receivables | 53,768,593.58 | 44,646,181.87 | | Including.: interest receivable | | | | Dividends receivable | | | | Financial assets purchased under
resale agreement | | | | Inventory | 3,480,329,471.17 | 3,336,332,619.58 |
| Including: data resources | | | | Contracted assets | | | | Assets held for sale | | | | Non-current assets that mature within
one year | | | | Other current assets | 323,583,331.44 | 329,901,506.56 | | Total current assets | 11,891,077,642.92 | 11,880,975,984.65 | | Non-current assets: | | | | Disbursed loans and advances | | | | Debt investments | | | | Other debt investment | | | | Long-term receivables | | | | Long-term equity investment | 1,306,518.96 | 1,445,021.57 | | Other equity instrument investment | | | | Other non-current financial assets | | | | Investment real estate | 8,356,156.61 | 8,512,192.20 | | Fixed assets | 2,189,183,083.45 | 2,008,437,417.28 | | Construction in progress | 296,063,689.71 | 395,645,781.60 | | Productive biological assets | | | | Oil and gas assets | | | | Assets with rights of use | 16,340,375.31 | 14,463,991.44 | | Intangible assets | 232,333,780.83 | 214,122,877.97 | | Including: data resources | | | | Development expenditure | 86,991,768.53 | 36,791,601.49 | | Including: data resources | | | | Goodwill | 94,866,025.56 | 94,866,025.56 | | Long-term deferred expenses | 31,909,393.75 | 34,125,613.10 | | Deferred income tax assets | 118,308,739.01 | 117,262,810.63 | | Other non-current assets | 92,139,375.96 | 91,304,780.64 | | Total non-current assets | 3,167,798,907.68 | 3,016,978,113.48 | | Total assets | 15,058,876,550.60 | 14,897,954,098.13 | | Current liabilities: | | | | Short-term loan | 3,007,176,826.17 | 2,261,455,023.95 | | Borrowings from the central bank | | | | Borrowing from banks and financial
institutions | | | | Financial liabilities held for trading | | | | Derivative financial liabilities | | 4,141,579.45 | | Notes payable | 3,164,565,144.94 | 4,057,148,069.12 | | Accounts payable | 1,160,483,609.93 | 1,096,628,295.09 | | Advance receipts | 490,412.00 | 232,358.87 | | Contract liability | 46,778,786.28 | 29,592,998.73 | | Financial assets sold for repurchase | | | | Deposits and interbank deposits
received | | | | Amount received from agency trading
of securities | | | | Amount received from agency
underwriting of securities | | | | Payroll payable | 156,692,121.15 | 218,457,162.23 | | Taxes payable | 125,548,394.22 | 77,730,510.55 | | Other payables | 80,407,289.60 | 81,107,290.26 | | Including: Interests payable | | | | Dividends payable | | | | Charges and commissions payable | | |
| Re-insurance accounts payable | | | | Liabilities held for sale | | | | Non-current liabilities due within one
year | 4,560,445.18 | 9,623,075.76 | | Other current liabilities | 23,007,785.61 | 57,442,707.33 | | Total current liabilities | 7,769,710,815.08 | 7,893,559,071.34 | | Non-current liabilities: | | | | Provision for insurance contracts | | | | Long-term loan | 111,160,672.69 | 77,624,331.91 | | Bonds payable | | | | Including: Preferred shares | | | | Perpetual bonds | | | | Lease liability | 8,903,219.19 | 8,219,602.23 | | Long-term payables | | | | Long-term payroll payable | | | | Accrued liabilities | | | | Deferred income | 11,476,461.96 | 11,713,887.21 | | Deferred income tax liabilities | 51,863,304.55 | 67,145,243.72 | | Other non-current liabilities | | | | Total non-current liabilities | 183,403,658.39 | 164,703,065.07 | | Total liabilities | 7,953,114,473.47 | 8,058,262,136.41 | | Owner’s equity: | | | | Share capital | 278,662,094.00 | 278,662,094.00 | | Other equity instruments | | | | Including: Preferred shares | | | | Perpetual bonds | | | | Capital reserve | 2,388,187,702.28 | 2,382,932,252.27 | | Less: Treasury stock | | | | Other comprehensive income | 33,105,376.93 | -53,797,771.67 | | Special reserve | 42,954,447.55 | 38,596,260.53 | | Surplus reserve | 158,674,657.07 | 158,674,657.07 | | General risk reserve | | | | Undistributed profit | 3,893,929,710.29 | 3,741,086,359.04 | | Total owners' equity attributed to
parent company | 6,795,513,988.12 | 6,546,153,851.24 | | Minority shareholder’s interest | 310,248,089.01 | 293,538,110.48 | | Total owner’s equity | 7,105,762,077.13 | 6,839,691,961.72 | | Total liabilities and owners’ equity | 15,058,876,550.60 | 14,897,954,098.13 |
Legal Representative: Wicky Wang Chief Accountant in Charge: Xing Bingpeng Chief of Accounting Institution: Zhang Baolin
2. Consolidated income statement
Unit: RMB
| Item | Amount incurred in Q1 2024 | Amount incurred in Q4 2023 | | I. Gross Operating Income | 2,693,191,598.95 | 2,233,266,009.68 | | Including: Operating income | 2,693,191,598.95 | 2,233,266,009.68 | | Interest income | | | | Premium earned | | | | Handling charges and
commissions income | | | | II. Total Operating Costs | 2,502,450,985.18 | 2,118,502,804.32 | | Including: Costs of business | 2,151,930,798.44 | 1,814,538,181.24 | | Interest expenses | | | | Handling charges and | | |
| commission expenses | | | | Surrender value | | | | Net payments for insurance
claims | | | | Net withdrawal of reserve for
insurance responsibility contracts | | | | Expenditures of policy
dividend | | | | Re-insurance expense | | | | Taxes and surcharges | 9,639,670.98 | 9,314,127.45 | | Sales expenses | 136,012,126.19 | 75,879,447.34 | | Management expenses | 95,232,946.97 | 102,590,984.82 | | R&D expenditures | 36,086,891.09 | 56,162,380.67 | | Financial expenses | 73,548,551.51 | 60,017,682.80 | | Including: Interest expenses | 21,851,106.77 | 5,399,475.19 | | Interest income | 11,765,988.38 | 15,704,126.01 | | Add: Other incomes | 1,590,381.16 | 2,246,880.15 | | Income from investment (“－”
for loss) | 5,221,370.46 | -35,302,194.73 | | Including: Income from
investment in associated enterprises and
joint ventures | -138,502.61 | -31,308.03 | | Income recognized
at termination of financial assets
measured at amortized cost | | | | Foreign exchange gain ("-" fro
loss) | | | | Net exposure hedging income ("-
" for loss) | | | | Income from changes in fair
value ("-" for loss) | 8,508,624.49 | 96,528,024.70 | | Credit impairment losses ("-" for
loss) | -15,533,971.25 | 27,806,314.28 | | Asset impairment losses ("-" for
loss) | -534,514.34 | -1,406,215.58 | | Gains from asset disposal ("-" for
loss) | 347,243.81 | | | III. Operating Profit ("-" for loss) | 190,339,748.10 | 204,636,014.18 | | Add: Non-operating income | 5,194,095.82 | 3,582,516.56 | | Less: Non-operating expenses | 5,506,355.00 | 5,029,861.03 | | IV. Total Profit Before Tax (“-” for total
losses) | 190,027,488.92 | 203,188,669.71 | | Less: Income tax expenses | 24,726,415.53 | 9,733,671.77 | | V. Net Profit ("-" for net loss) | 165,301,073.39 | 193,454,997.94 | | (I) Classification by business continuity | | | | 1. Net profit from continuing
operations (“-” for net loss) | 165,301,073.39 | 193,454,997.94 | | 2. Net profit from discontinued
operations (“-” for net loss) | | | | (II) Classification by ownership | | | | 1. Net profit attributable to the | 152,843,351.25 | 182,814,094.72 |
|
